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Abstract
Purpose: Obesity is a well-known of risk factor for atherosclerosis. However, recently an “obesity paradox” has been 
discussed, which is considered as a protective effect of obesity on the development coronary artery disease (CAD). 
An aim of the study was to investigate the risk of CAD in morbidly obese patients using coronary artery calcium 
measurement.
Material and methods: Fifty-one patients with morbid obesity (BMI ≥ 40 kg/m2) and thirty controls were scanned 
to determine the amount of coronary artery calcification (CAC), which was expressed as calcium score (CS) and 
coronary age (CA). The control group consisted of patients scanned for the clinical suspicion of CAD, who did not 
fulfil the criteria of obesity.
Results: Mean BMI of obese patients and controls was 47.3 and 26.5, respectively (p < 0.0001). Arterial hypertension, 
dyslipidaemia, and smoking were more frequent in the control group than in the obesity group (p < 0.02). The prev-
alence of CAC was higher in the obesity group (53% vs. 23%, p < 0.01). The groups did not differ regarding CS and 
CA. However, the difference between coronary age and metrical age was higher in obese patients than in controls 
(+5.6 vs. –4.8 years, respectively, p < 0.005).
Conclusions: Patients with morbid obesity present an increased risk of CAD that is reflected by the difference between 
their coronary age and metrical age.
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Introduction
There is a long-known adage, attributed to the famous 
English physician Thomas Sydenham (1624-1689): 
“you’re only as old as your arteries”. However, for many 
years only metrical age was used by clinicians trying to 
assess the cardiovascular risk of their patients via scales 
such as the Framingham scale. In this scale, used to calcu-
late 10-year coronary risk, the age of patients is taken into 
account in addition to other factors. Nowadays it appears 
that although the calculated absolute risk values (especially 
among middle-aged patients) are often relatively low, the 
relative risk is unexpectedly high. Hence the idea of “car-
diac age” or “coronary age” was born. It is still a relatively 
new concept. It seems that Grundy was the first to postu-
late in 1999 the use of biological age, based on evidence of 
arteriosclerosis, instead of the previously used chronologi-
cal age, to estimate the cardiovascular risk by Framingham 
scale [1]. Although the advancement of atherosclerosis 
progresses with age, there is great individual variability at 
the onset and the speed of progression of atherosclerotic 
process. This may result in overestimation or underestima-
tion of risk. That is why recently it has been postulated that 
arterial age be included in global risk scales. 
Obesity is considered as a risk factor for the early de-
velopment of atherosclerosis and cardiovascular disease. 
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In recent studies not the total amount of body fat but rath-
er its specific regional distribution is considered as a risk 
factors for cardiovascular disease. In this context, many 
studies have focused on intra-abdominal adipose tissue, 
which has features of an active endocrine gland and se-
cretes a number of hormones and atherogenic cytokines 
known as adipokines [2]. Pericardial adipose tissue is 
considered a part of visceral fat, and it is believed that, 
in addition to systemic effects of adipokines, it can exert 
a local atherogenic effect on the coronary arteries [3]. Pa-
tients with morbid obesity are a special group of patients 
because they present multiple individual risk factors of 
atherosclerosis, some of which may enhance atherogenic 
effect due to interactions.
However, recently multiple reports have emerged, in 
which the direct association of obesity with the develop-
ment of atherosclerosis is questioned. In some patients 
with obesity, and in some pathologies, an increased sur-
vival rate is observed compared to people with normal 
body mass. This phenomenon has been termed the “obe-
sity paradox” or “reversed epidemiology”. Such a para-
doxical relationship of high body mass index (BMI) 
with better forecasts has already been described in pa-
tients with chronic renal disease, chronic heart failure, 
chronic obstructive pulmonary disease, and in patients 
with coronary heart disease [4]. This observation is ex-
plained by the fact that the nature and location of body 
fat, and not its total amount in the body, are risk factors 
for these diseases. Because subcutaneous adipose tissue 
is metabolically nearly inactive in comparison to viscer-
al fat, its dominance in the body could actually explain 
the phenomenon of “reversed epidemiology”. Recent 
studies have even shown that in healthy individuals, an 
increased amount of subcutaneous adipose tissue has 
a protective effect, inhibiting the development of ather-
osclerosis [5]. The phenomenon of the obesity paradox 
encourages further research, especially in the context of 
linking it with clusters of adipose tissue in particular ar-
eas of the body.
An aim of the study was to investigate the risk of CAD 
in morbidly obese patients using coronary artery calcium 
measurement.
Material and methods
In this prospective study we evaluated 51 subjects with 
morbid obesity, who were scheduled for bariatric sur-
gery procedures in our hospital. Inclusion criteria were 
as follows: morbid obesity (BMI ≥ 40 kg/m2) and lack of 
consistent effect of conservative treatment of obesity re-
sulting in referral to bariatric surgery. Exclusion criteria 
included: body weight over 220 kg (scanner’s table limit), 
inability to fit the scanner’s gantry, dyspnoea in supine 
position, previous coronary stenting or coronary surgery, 
arrhythmia or tachycardia, pregnancy, and age below 
18 years. Due to possible ethical concerns, a control group 
of 30 subjects was composed retrospectively of patients 
who were scanned due to clinical suspicion of coronary 
artery disease and who did not fulfil obesity criteria. Ex-
clusion criteria were similar as in the study group. The 
study protocol was approved by a bioethical commission 
of our university, and all subjects gave their informed con-
sent for participation in the study. 
All subjects underwent an ECG-gated cardiac CT 
scanning according to the coronary calcium scoring pro-
tocol using a 64-row Philips Brilliance unit [6,7]. Acquisi-
tion of data was performed in 2.5-mm slices at 120 kV and 
75 mAs, with an FOV of 220 mm. No intravenous con-
trast media nor premedication were used. Standard 
Philips Brilliance Workstation with HeartBeat CS appli-
cation were used to evaluate the presence and quantity of 
coronary artery calcium (CAC). 
Measurement of the calcium score (CS) was carried 
out in a semi-automatic manner. In the initial stage the 
software distinguished calcifications on CT scans accord-
ing to Agatston et al.’s criteria [8]. Then a reader was need-
ed to identify coronary arteries at the axial cross-sections 
of the heart and to manually indicate highlighted calci-
fications. Other types of calcifications (such as calcified 
heart valves or picture noise erroneously classified by the 
algorithm as calcifications) were neglected by the reader. 
Then, the application automatically calculated Agatston’s 
CS. Due to the high skewness of CS values, the data were 
log-transformed before statistical analysis [6]. 
Distribution of CS values within both groups was 
compared to the general population values using data 
from the German Multislice Normal Incidence of Cor-
onary Health (MUNICH) Registry [9]. Apart from con-
ventional CS, we also used coronary age (CA) as an al-
ternative function of CAD risk. CA is defined as the age 
of a healthy person (without risk factors) who presents 
a risk of coronary heart disease equal to the risk calculated 
for the analysed patient. For example, if a coronary age of 
65 years is calculated in 55-year-old patient, it means that 
the cardiovascular risk expressed by the amount of coro-
nary calcifications is equal to that of a healthy 65-year-old 
individual. For the purpose of this study, patients’ coro-
nary age was determined by means of a commonly avail-
able on-line MESA-based tool [10,11].
Quantitative variables were expressed as mean with 
95% confidence intervals (95% CI). Statistical analysis was 
performed using MedCalc v. 14 (MedCalc Software bvba, 
NL). Normality of the data was tested using the Kolmogor-
ov-Smirnov test. Differences in quantitative data were test-
ed using the independent samples t-test. Comparison of 
qualitative data was performed using the Chi-squared test. 
P-values of 0.05 were considered statistically significant.
Results
The participants were aged between 19 and 71 years 
(mean 46.8 years). Cardiac CT scanning was completed 
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in all subjects without premedication. The mean heart rate 
during the acquisition was 73 BPM. Both groups statisti-
cally significantly differed regarding body weight, height, 
and BMI. Common risk factors for atherosclerosis, i.e. 
hypertension, diabetes, nicotine, and dyslipidaemia, were 
more frequent in the control group than in obese patients, 
and only in the case of diabetes was the difference not sta-
tistically significant. Detailed demographic characteristics 
of the study groups are given in Table 1.
The prevalence of CAC was higher in morbidly obese 
patients than in controls (p = 0.0091) (Table 2). In the 
obesity group, calcifications were detected in 27 individ-
uals, and CS ranged from 1 to 2453. A value greater than 
the 50th centile was reached by 51% of subjects (Figure 1). 
The CA of patients ranged from 19 to 96 years, and 47% of 
the patients were above the metrical age (Figure 2). In the 
control group, calcifications were detected in seven sub-
jects, and CS ranged from 1 to 346. Only 23% of controls 
had CAC over the 50th centile (Figure 1). The majority 
(63%) of controls had CA lower than their metrical age 
(Figure 2).
The mean number of calcifications was higher in the 
study group than in the control group, but the difference 
was of borderline significance. However, the difference 
between coronary age and metrical age was significant-
ly higher in obese patients than in controls (p = 0.0023) 
(Table 2). The ROC curve analysis confirmed that the 
difference between CA and metrical age presented the 
strongest relation with obesity (Table 3).
Table 1. Demographic characteristics of the study groups. Mean values (95% confidence interval) or structural indices and p-values for the differences are given
Parameter Study group Control group p
Gender (females) 66.7% 60.0% 0.0663
Metrical age (years) 44.1 (40.9-47.3) 51.8 (47.9-55.7) 0.0723
Body weight [kg] 128.9 (124.1-133.8) 76.5 (71.4-81.6) 0.0000
Height [m] 1.65 (1.63-1.67) 1.70 (1.67-1.73) 0.0024
BMI 47.3 (45.7-48.9) 26.5 (24.9-28.0) 0.0000
Hypertension 35% 70% 0.0023
Diabetes 18% 30% 0.2113
Smoking 16% 43% 0.0075
Dyslipidaemia 22% 47% 0.0191
Table 2. Results of measurement of coronary calcifications. Mean values (95% confidence interval) or structure index and significance level in t-test are given
Parameter Study group Control group p
Prevalence of calcifications 52.9% 23.3% 0.0091
Calcium score 91.9 (0.0-189.4) 45.6 (8.2-83.0) 0.0661
Coronary age [years] 49.6 (44.9-54.4) 47.0 (41.3-52.7) 0.5057
Difference between coronary and metrical age [years] +5.55 (1.51-9.59) –4.77 (–10.02; –0.48) 0.0023
Figure 1. Percentile distribution of calcium score (CS) values in the study 
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Figure 2. Distribution of the difference between coronary age (CA) and 
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Discussion
In our study we showed that patients with morbid obesity 
present an increased coronary age. In this study, the num-
ber of calcifications in the coronary arteries and derivative 
parameters were adopted as the primary indicators of risk 
for atherosclerosis. Our results indicate that obesity is as-
sociated with an increased risk of coronary atherosclero-
sis, which is reflected by a higher incidence of calcification 
in the study group compared to the control group. Inter-
estingly, the difference between CA and metrical age pre-
sented the strongest relation to obesity. Therefore, it may 
be concluded that this parameter potentially may become 
a useful method for estimating the risk of cardiovascular 
events in people with extreme obesity. It also seems to be 
a unique finding because, according to our knowledge, the 
concept of the difference between coronary and metrical 
age has not been studied before. 
Calcium scoring has been shown to be reproducible 
and predictive of a variety of adverse outcomes of CAD. 
Moreover, progression of calcifications correlates with se-
verity of CAD, which adds to the predictive value of this 
test [9,10]. Of course, coronary computed tomography 
angiography (CTA) would offer much more information 
on the status of coronary arteries than calcium scoring. 
However, the main drawbacks of CTA include much 
higher radiation dose and the risk of contrast-induced 
nephropathy (CIN) [12], which makes CTA inefficient 
as a screening tool. CIN is of particular importance be-
cause atherosclerosis remains an important risk factor of 
this pathology [12]. Nevertheless, little is known about 
the impact of obesity on the early development of ather-
osclerosis. The early studies, such as the Seven Countries 
Study (1984), revealed only a negligible correlation be-
tween body weight and the incidence of coronary heart 
disease. In the Pathological Determinants of Atheroscle-
rosis in Youth (PDAY) study, BMI and subcutaneous fat 
thickness were positively correlated with the pathomor-
phological signs of early atherosclerosis in young men, but 
not in young women [13]. However, the large MESA study 
indicated that obesity is associated with an increased risk 
of atherosclerosis, which manifested, among others, by 
1.2-fold higher incidence of calcification in the coronary 
arteries in obese patients compared with people of normal 
weight [14]. Today, the efforts of researchers tend to fo-
cus on determining the impact of the regional distribution 
of fat and subtypes of fat on the development of athero-
sclerosis. Among the available publications, particularly 
noteworthy is the work of Gadelha et al., who conducted 
their research on a population similar to ours, i.e. patients 
without known coronary artery disease, scheduled for 
bariatric surgery. The researchers noticed the presence of 
coronary CAC in 14% of participants, including 26% of 
men and 11% of women. They also underlined that the 
study participants with CAC were generally older (average 
age 46.8 years) than patients without calcifications in the 
coronary arteries (mean age 34.3 years). Other variables, 
showing the relationship with the CAC, included: male 
gender, type 2 diabetes, hypertension, and hypercholes-
terolaemia [15]. In our own material, calcifications in the 
coronary arteries in morbidly obese patients occurred 
much more frequently (52.9%), wherein our patients 
were more obese than in the above-quoted paper (mean 
BMI was 47.3 vs. 40.5). Similarly, the results of the cohort, 
long-term CARDIA (Coronary Artery Risk Development 
in Young Adults) study suggested that abdominal obesi-
ty, assessed by waist circumference and waist-hip ratio 
(WHR) in young adults during a 15-year follow-up pe-
riod, was directly linked with a higher incidence of coro-
nary atherosclerosis [16]. Similar results were seen in the 
St. Francis Heart Study, in which abdominal obesity eval-
uated with WHR and amount of visceral fat positively 
correlated with the amount of CAC in people aged 50-70 
years [17]. Meanwhile, Cassidy et al. analysed the coin-
cidence of coronary calcifications with, for example, ab-
dominal circumference, WHR, and BMI and discovered 
that expected annual growth of CAC in overweight people 
is about 51% higher than in people with underweight and 
normal weight [18]. In turn, the Muscatine Study demon-
strated that excessive weight gain during childhood (8-18 
years) and the calculated BMI in the age of 20-34 years 
were positively associated with the presence of calcifica-
tions in the coronary arteries later in life, i.e. in the age 
range 29-37 years [19]. 
The literature review gives grounds to believe that the 
vascular age indeed allows us to improve the efficiency of 
determining the cardiovascular risk. For example, Shaw 
et al. utilised CAC measurements performed in a group 
of 10,377 asymptomatic participants in order to assess the 
risk of death and then the number of life-years lost. Their 
results indicated a direct relationship between chronolog-
ical age and the number of calcifications in the coronary 
Table 3. Analysis of the ROC curve for the relationship between obesity and analysed morphological parameters. Only statistically significant relationships 
are shown
Parameter AUC (95% CI) p Threshold Sensitivity Specificity
Prevalence of coronary calcifications 0.64 (0.53-0.75) 0.0069 > 0 52 77
Calcium score 0.63 (0.52-0.74) 0.0302 > 0.1 58 77
Coronary age [years] 0.71 (0.60-0.81) < 0.0001 ≤ 44 58 90
Difference between coronary and metrical age [years] 0.72 (0.61-0.81) 0.0005 > –6 82 63
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arteries, and also allowed them to create their own linear 
predictive model. According to the researchers, CS be-
low 10 in patients aged over 70 years was equivalent to 
a reduction in biological age by 10 years. In contrast, CS 
> 400 in younger patients “added” up to 30 years of chron-
ological age. In their material, the age modified in relation 
to the number of calcifications was also a better predictor 
of mortality than chronological age. With regard to the 
Framingham scale, utilisation of the modified age resulted 
in reclassification of patients from a low-risk to an inter-
mediate risk group in 55% of cases, and 45% of those at 
medium risk to high risk [20]. Similar results were ob-
tained by Nasir et al. In their material, CS ranging from 
the 75th to the 90th percentiles added 10 years to metrical 
age, while exceeding the 90th percentile increased the age 
by 20 years. In contrast, in patients in age where the CS > 0 
falls within the normal range (i.e. in men above the age 
of 55 and in women above the age of 65 years), CS = 0 
reduced the age to 40-44 years and 55-59 years, respec-
tively [21].
There are also limitations to our study that should be 
addressed. Firstly, our sample size was calculated with as-
sumption for the largest possible effect. This might have led 
to the underestimation of the sample size to get statistical 
significance of the difference in the total CAC load. In fact, 
the difference in CS between the obesity group and control 
group is large and should be statistically significant when 
including a larger number of subjects. Secondly, selection 
of the control group should be discussed. Due to ethical 
concerns, exposition of healthy individuals to the radiation 
was not acceptable. Therefore, we used a group of subjects 
who were scheduled for a diagnostic coronary CT angio-
graphy. As a result, our control group participants might 
have more risk factors of atherosclerosis. To compensate 
for this we used centile ranks based on the MESA study 
as a reference. On the other hand, because our controls 
were slightly older than obesity patients, a direct compari-
son of CA showed a non-significant difference. Therefore, 
we used the difference between CA and metrical age as 
the method of coronary risk estimation. Finally, we used 
a CA estimation system based on the American popula-
tion, which is more heterogeneous than the European one. 
However, this discrepancy might not limit the soundness 
of our conclusions because in general Americans tend to 
present no less risk of CAD than Europeans. 
Conclusions
We found that morbid obesity is associated with an in-
creased coronary age, which may reflect the raised cardi-
ovascular risk in obese patients. However, further studies 
on larger populations and with follow-up are necessary 
to determine the actual usefulness of coronary age in the 
prediction of cardiovascular events.
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